The below Parliamentary question was asked by Phil Boswell on 2016-02-05.
To ask the Minister for the Cabinet Office, whether any proposed special advisers have failed security vetting since May 2010.
Matthew Hancock
It has been the policy of successive governments not to comment about the individuals subject to security vetting.
The below Parliamentary question was asked by Paul Blomfield on 2016-03-02.
To ask Mr Chancellor of the Exchequer, pursuant to the Answer of 1 March 2016 to Question 25631, when he expects the investigations into the six social care companies to be concluded.
Mr David Gauke
If a worker believes they have not received at least the National Minimum Wage they should contact the Acas helpline in confidence on 0300 123 1100. HM Revenue and Customs (HMRC) currently fast track for investigation any care worker direct complaints received through the Acas helpline.
I refer the hon. member back to the answer provided to him to Question 25631 for HMRC’s position on discussing outcomes. I further refer the hon. member back to the answer provided to him by my hon. friend the Minister for Skills (Nick Boles) for detail on naming policy, Question 8685.
The most recent naming announcement from February is available at: https://www.gov.uk/government/news/new-national-minimum-wage-offenders-named-and-shamed-february-2016.
“
The below Parliamentary question was asked by Baroness Gale on 2016-03-23.
To ask Her Majesty’s Government what assessment they have made of the impact on the NHS of NHS England cutting the role of National Clinical Director for Adult Neurology, and the end of national funding for neurological work by clinical networks.
Lord Prior of Brampton
Sir Bruce Keogh, NHS England’s Medical Director, has undertaken a review of the National Clinical Director (NCD) resource designed to focus clinical advisory resources on areas where major programmes of work are currently being taking forward, or areas identified as priorities for improvement. As a result of the review, NHS England has proposed to change the way in which clinical advice is received in speciality areas in the future, streamlining and strengthening its clinical advisory mechanisms in support of the Five Year Forward View and the National Health Service’s key improvement priorities.
Whilst there will no longer be a specific NCD role for neurology, NHS England will continue to secure expert clinical advice from its Clinical Networks and through its relationships with professional bodies and by appointing clinical advisors. Access to advice will be through clinical leads and members of the NHS England-funded neurology clinical networks, the Neurology Clinical Reference Group and Royal Colleges. It is expected that these new arrangements will be in place shortly.
During 2016/17, the focus of NHS England’s improvement efforts delivered through Strategic Clinical Networks will be on a smaller range of key national priorities, including cancer, mental health, diabetes, maternity and urgent and emergency care (with a focus on cardiovascular disease transformation). Whilst there is no additional funding nationally, clinical and local networks of care can determine what can be done at a local or regional level if it is considered a local or regional system priority. Nationally, the policy team is considering how key aspects of the work on neurology can be taken forward through alternative mechanisms and partners.
In addition, the Neurology Intelligence Network (NIN) is a joint partnership programme between Public Health England (PHE) and NHS England to support the generation and dissemination of neurology related health intelligence. PHE currently funds the on-going design, development and management of the NIN.
The below Parliamentary question was asked by Bridget Phillipson on 2016-05-04.
To ask the Secretary of State for Work and Pensions, when his Department plans to publish its response to its public consultation on housing benefit reform and supported housing.
Justin Tomlinson
In conjunction with the Department for Communities and Local Government, the Department for Work and Pensions has recently conducted an evidence-based review of supported accommodation in GB and we expect to publish the report shortly. Alongside this work, as part of our policy review, we will continue to work with and listen to all relevant stakeholders, including the supported housing sector in order to develop a workable and sustainable funding regime.
The below Parliamentary question was asked by John Redwood on 2016-06-20.
To ask the Secretary of State for Justice, which EU (a) legislative and (b) other proposals his Department is leading negotiations on for the Government in the Council of the EU.
Dominic Raab
This Department is currently leading negotiations on the following legislative proposals:
The following are ongoing negotiations within my department’s remit that the UK does not participate in. My department, however, monitors the negotiations to ensure that these proposals do not negatively impact UK interests.
The below Parliamentary question was asked by Lord Ouseley on 2016-09-05.
To ask Her Majesty’s Government how many individuals have been tasered by the police in England since 2012 and what protected diversity characteristics applied to each individual.
Baroness Williams of Trafford
The Home Office publish police use of TASER ® X26 statistics annually on GOV.UK. These releases contain statistics on police use of TASER ® X26 from the 43 Home Office police forces in England and Wales up to 2015. Protected diversity characteristics do not form part of this collection. The table below shows total police use of TASER ® X26 across England and Wales since 2012.
|
2012 |
2013 |
2014 |
2015 |
Total use of TASER ® X26 since 2012 |
|
|
Number of times TASER ® X26 was used |
8,161 |
10,380 |
10,095 |
10,401 |
39,037 |
Source: Home Office
Following the former Chief Constable David Shaw Use of Force Data review, published in July 2016, a new data collection is being implemented by the police which will allow for some protected characteristic data from 2016. We expect the data collected to be published locally by police forces and a sub-set of the data to be included in the mandatory annual data return for forces in 2017/18 for publication as Official Statistics. The current TASER publications can be found at: https://www.gov.uk/government/collections/use-of-taser-statistics
The below Parliamentary question was asked by Roger Godsiff on 2016-10-20.
To ask the Secretary of State for Defence, how many times his Department has referred suspicions or allegations of corruption to law enforcement authorities since 2011.
Mark Lancaster
Since 2011 Fraud Defence has referred 44 reported suspicions/allegations of corruption/bribery to law enforcement authorities.
The Ministry of Defence takes allegations of Fraud, Theft, Corruption and Bribery seriously and works hard to detect and deter it. There are robust processes in place to raise awareness of the need for vigilance and we actively encourage individuals to report Fraud, Theft, Corruption and Bribery.
The below Parliamentary question was asked by Kevin Barron on 2016-01-13.
To ask the Secretary of State for Health, what discussions he has had with the Medicines and Healthcare Products Regulatory Agency about the requirement for some generic medicines to be given a brand name for clinical reasons; and what steps he is taking to ensure patients receive the brand name medicine specified.
George Freeman
The Medicines and Healthcare products Regulatory Agency (MHRA) is the Executive Agency of Department of Health with overall responsibility for medicines licensing.
The responsibility for prescribing rests with the practitioner who has clinical responsibility for their patient’s care and we would expect practitioners to take any relevant guidance into account when making their prescribing decisions.Prescribers utilise a wide range of information to inform their prescribing decisions including decision support systems and authoritative guidance such as that from the MHRA, the National Institute for Health and Care Excellence and the British National Formulary.
In primary care, if it is clinically appropriate for an individual patient to be maintained on a specific manufacturer’s product then the prescriber can specify this on the prescription for that product to be dispensed. Officials from the Department and MHRA liaise as required on the application of this policy.
The below Parliamentary question was asked by Corri Wilson on 2016-02-05.
To ask Mr Chancellor of the Exchequer, what assessment he has made of the incidence of members of the public receiving multiple letters from HM Revenue and Customs (HMRC) conveying conflicting information; and what steps HMRC is taking to reduce such occurrences.
Mr David Gauke
HM Revenue and Customs (HMRC) does not hold this data. However, they regularly publish general performance reports at Gov.uk.
The below Parliamentary question was asked by Andrew Murrison on 2016-03-02.
To ask the Secretary of State for Culture, Media and Sport, what assessment he made of the flag flying policies adopted by other European states in respect of national monuments in developing his policy on that matter.
David Evennett
No specific assessment has been made of the policy adopted by other European states in respect of national monuments. The decision as and when to fly flags is largely a decision for individual organisations.